The traditional Chinese practice of qigong can effectively alleviate chronic low back pain (CLBP), according to a study ...

Samaritan Medical Center is closing its Pain Management Center at the end of February because it’s “not meeting the ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Understanding the link between weight and arthritis pain could be key to finding relief. Learn how small changes in lifestyle can make a big difference.

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

A new study shows Minnesota's medical cannabis program has yielded meaningful results in pain reduction amongst patients.

Virtual reality has been a standout technology in the medical industry since the turn of the decade. From its use as a ...

A new study using Mendelian randomization suggests that higher copper levels may increase fibromyalgia risk, while iron may ...